MedPath

iovel Combination Tablets special drug use surveillance Long-term use in patients with type 2 diabetes mellitus

Not Applicable
Conditions
Type 2 diabetes mellitus
Registration Number
JPRN-jRCT1080222253
Lead Sponsor
TAKEDA PHARMACEUTICAL COMPANY LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
3000
Inclusion Criteria

Patients with type 2 diabetes mellitus

Exclusion Criteria

Patients meeting any of the following criteria will be excluded:
1. Patients with current cardiac failure or a past history of cardiac failure
2. Patients with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus
3. Patients with serious hepatic dysfunction
4. Patients with serious renal dysfunction
5. Patients with severe infection, pre- or post-operative patients, or patients with serious traumatic injury
6. Patients with a history of hypersensitivity to any ingredients of Liovel
7. Pregnant or possibly pregnant wome

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath